Analysis of protein phosphorylation in cisplatin-treated human cells following annexin V-based separation and

Elaine O'Meara1, Séverine Cruet-Hennequart, Michael P Carty

  • 1DNA Damage Response Laboratory, Centre for Chromosome Biology, School of Natural Sciences, National University of Ireland, Galway, Galway, Ireland.

Insights

Chemotherapy drug cisplatin triggers DNA damage response (DDR) pathways. Researchers identified altered protein phosphorylation in apoptotic cells, revealing new insights into cancer cell death mechanisms.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Cancer chemotherapy utilizes DNA-damaging agents like cisplatin to induce tumor cell death.
  • The DNA damage response (DDR) orchestrates cellular reactions to genotoxic stress, including cell cycle arrest, DNA repair, and apoptosis.

Purpose of the Study:

  • To investigate the relationship between DDR signaling and cellular outcomes following cisplatin exposure.
  • To characterize apoptosis-associated protein phosphorylation changes in response to cisplatin.

Main Methods:

  • Utilized magnetic-activated cell sorting (MACS®) to isolate apoptotic and non-apoptotic cells from a DNA polymerase eta-deficient human cell line.
  • Employed multi-antibody screening to identify changes in protein phosphorylation patterns.

Main Results:

  • Observed altered phosphorylation of RPA2 (Replication Protein A 2) on serine 4/8 in apoptotic cells after cisplatin treatment.
  • Detected increased phosphorylation of Erk1 (Extracellular signal-regulated kinase 1) and Erk2 (Extracellular signal-regulated kinase 2) in apoptotic cells.

Conclusions:

  • The study provides novel insights into the specific protein phosphorylation events linked to cisplatin-induced apoptosis.
  • Characterization of DDR signaling in apoptotic cells offers a deeper understanding of chemotherapeutic agent efficacy.

Related Concept Videos